Aria Pharmaceuticals

📍 Palo Alto, United States🗓 Founded 2014👥 4 employees💰 Last funded Oct 2021
Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases. Too many patients today are in need of breakthrough treatments across many complicated diseases – they can’t wait. That’s why at Aria, we have redefined the drug discovery approach, saving years in the process and increasing success rates 30 times higher than traditional methods. At Aria, we’ve shown promise across a diverse range of therapeutic areas with the ability to address over 1,000 diseases.
5
Total investors
1
Early stage
1
Mid stage
3
Late stage
2014
Founded
Investor geography4 countries
Israel
2
Malta
1
United States
1
Portugal
1
Investor activity2015–2021 · investors recorded per year
201512018120213
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Aria Pharmaceuticals?
Aria Pharmaceuticals has 5 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 3 late-stage investors.
When did Aria Pharmaceuticals last raise funding?
The most recent investment in Aria Pharmaceuticals recorded on gritt.io was in October 2021.
When was Aria Pharmaceuticals founded?
Aria Pharmaceuticals was founded in 2014.
What industry is Aria Pharmaceuticals in?
Aria Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Aria Pharmaceuticals based?
Aria Pharmaceuticals is headquartered in Palo Alto, United States.